Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Queensland Health
Julphar
Express Scripts
Covington
McKinsey
Fuji
Federal Trade Commission
Cipla

Generated: June 20, 2018

DrugPatentWatch Database Preview

NEMBUTAL SODIUM Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Nembutal Sodium patents expire, and when can generic versions of Nembutal Sodium launch?

Nembutal Sodium is a drug marketed by Oak Pharms and is included in four NDAs.

The generic ingredient in NEMBUTAL SODIUM is pentobarbital sodium. There are two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the pentobarbital sodium profile page.
Drug patent expirations by year for NEMBUTAL SODIUM
Synonyms for NEMBUTAL SODIUM
10579-81-4
2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(1-methylbutyl)-, monosodium salt
2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(1-methylbutyl), monosodium salt
23714-57-0
5-Ethyl-5-(1-methylbutyl) barbituric acid sodium salt
5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione monosodium salt
5-Ethyl-5-(1-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione Sodium Salt
5-ethyl-5-(1-methylbutyl)-4,6-dioxo-1H-pyrimidin-2-olate
5-Ethyl-5-(1-methylbutyl)barbituric acid sodium salt
57-33-0
76-74-4 (Parent)
8023-11-8
8050-99-5
AC1Q1VYR
AKOS005111157
AN-23581
API0003787
ARONIS23861
Auropan
Barbituric acid, 5-ethyl-5-(1-methylbutyl)-, sodium salt
Barbituric acid, 5-ethyl-5-sec-pentyl-, sodium salt
Barpental
Biosedan
Butylmethyl ethyl malonyl urea sodium
Butylone [Barbiturate]
C07423
CHEBI:7984
Continal
D00500
DEA No. 2270
Diabutal
DTXSID9021712
EINECS 200-323-9
Embutal
Etaminal sodium
Ethaminal sodium
Eutha 77
Euthanyl
Euthatal
FT-0650678
Isobarb
Lethobarb
LS-24391
MCULE-2611041665
Mebubarbital sodium
Mebumal sodium
Mebunat
Mintal
MLS001306463
MolPort-002-561-071
Napental
Narcoren
Nembutal sodium (TN)
NSC 10816
P0776
Pacifan
Palapent
Penbar
Pentabarbital sodium
Pental
PENTOBARBITAL SODIUM
Pentobarbital Sodium (JAN/USP)
Pentobarbital sodium [USP:JAN]
Pentobarbital sodium salt
Pentobarbitone sodium
Pentonal
Pentone
Pentosol
Propylmethylcarbinylethyl barbituric acid sodium salt
QGMRQYFBGABWDR-UHFFFAOYSA-M
Rivadorn
RS-Pentobarbital sodium
SCHEMBL1247
Sedalixir
SMR000718804
sodium 5-ethyl-5-(1-methylbutyl)-4,6-dioxo-1,4,5,6-tetrahydropyrimidin-2-olate
sodium 5-ethyl-5-(1-methylbutyl)-4,6-dioxo-1H-pyrimidin-2-olate
Sodium 5-ethyl-5-(1-methylbutyl)barbiturate
Sodium ethaminal
Sodium nembutal
Sodium pentobarbital
Sodium pentobarbitone
Sodium pentobarbiturate
Sodium-Pent
sodium;5-ethyl-4,6-dioxo-5-pentan-2-yl-1H-pyrimidin-2-olate
Soluble pentobarbital
Somnopentyl
Sonistan
Sontobarbital nabitone
Sopental
Sotyl
STOCK2S-15760
V-Pento
Vetbutal

US Patents and Regulatory Information for NEMBUTAL SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Oak Pharms NEMBUTAL SODIUM pentobarbital sodium CAPSULE;ORAL 084095-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Oak Pharms NEMBUTAL SODIUM pentobarbital sodium INJECTABLE;INJECTION 083246-001 Approved Prior to Jan 1, 1982 AP RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Oak Pharms NEMBUTAL SODIUM pentobarbital sodium CAPSULE;ORAL 084093-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Oak Pharms NEMBUTAL SODIUM pentobarbital sodium CAPSULE;ORAL 083245-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Healthtrust
Daiichi Sankyo
Julphar
Citi
Covington
Boehringer Ingelheim
Farmers Insurance
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.